IHA is at the center of healthcare advocacy in Washington, D.C. Our efforts focus on legislation in Congress and policy proposals within federal regulatory agencies to advance healthcare in Illinois.
U.S. Reps. Michael Bost, Rodney Davis and Randy Hultgren from Illinois signed a letter in support of maintaining tax-exempt status for private activity bonds in the final tax reform bill.
IHA supported the Drug-price Transparency in Communications Act to address recent dramatic increases in prices for generic and specialty prescription drugs.
Ask your U.S. Representative to co-sponsor H.R. 4392 to protect the 340B Drug Pricing Program from a 30 percent pay reduction that could cost hospitals $1.6 billion.
Illinois Sens. Richard J. Durbin and Tammy Duckworth, along with a majority of U.S. senators, urged federal officials to protect the 340B Drug Pricing Program.
Fifteen U.S. representatives from Illinois joined a majority of House members in asking federal officials to abandon proposed changes to the 340B Drug Pricing Program.
Urge Congress to support Rural Medicare Extenders. Funding for the Medicare-dependent hospital and enhanced low-volume adjustment programs expires Sept. 30, 2017.
Learn more about Illinois' 223 hospitals, which together have 1.5 million inpatient admissions and 38 million outpatients visits a year.
Pharmaceutical manufacturers participating in Medicaid must discount outpatient drugs to qualifying hospitals and other providers who see a large number of low-income patients and rural populations.
IHA looked at lost spending, econmic impacts and Medicare cuts by Congressional District in our preliminary estimates of repealing the Affordable Care Act without a replacement plan.
See IHA's talking points on the Inpatient Prospective Payment System proposed rule on the phase-in of Worksheet S-10 data for uncompensated care that hospitals provide beginning in FFY 2018.